States / U.S. Congress / HR 1632

HR 1632 In Committee

Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2025

Introduced
In Committee
Floor
Crossed Over
Passed
Enacted
Introduced in House Feb 26, 2025 · 1.6K words Open full page ↗

I

119TH CONGRESS

1ST SESSION

H. R. 1632

To amend the Federal Food, Drug, and Cosmetic Act to provide for reciprocal

marketing approval of certain drugs, biological products, and devices

that are authorized to be lawfully marketed abroad, and for other pur-

poses.

Sign in to read the full text

The document summary and details above are public. The full text is available to signed-in accounts.